


Polaris Pharmaceuticals
Pharmaceutical Manufacturing • San Diego, California, United States • 21-50 Employees
Company overview
| Headquarters | 6370 Nancy Ridge Drive, Suite 106, San Diego, CA 92121, US |
| Website | |
| NAICS | 3254 |
| Keywords | Adi-Peg 20 (Oncology), Ck2 Inhibitor, Tnf-Peg 20, Uricase-Peg 20 |
| Founded | 2006 |
| Employees | 21-50 |
| Socials |
Key Contacts at Polaris Pharmaceuticals
Mirla Langlois
Associate Director Clinical Trial Management
Dawn Batten Navis
Associate Director, Pharmacovigilance
Shaw T. Chen
Chief Executive Officer
Philip Chang
Executive Director Finance
Polaris Pharmaceuticals Email Formats
Polaris Pharmaceuticals uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@polarispharma.com), used 85.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@polarispharma.com | 85.7% |
{first name}{last name} | johndoe@polarispharma.com | 7.1% |
{last name}{last name} | doedoe@polarispharma.com | 7.1% |
About Polaris Pharmaceuticals
Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans. Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma. Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia. Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.
Polaris Pharmaceuticals revenue & valuation
| Annual revenue | $7,600,000 |
| Revenue per employee | $304,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $24,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Polaris Pharmaceuticals has 14 employees across 8 departments.
Departments
Number of employees
Funding Data
Polaris Pharmaceuticals has never raised funding before.
Frequently asked questions
4.8
40,000 users



